131

Lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1 (Sp263) information, 63 cases/126 cores

Lung cancer tissue array, including pathology grade��� 120 cases/120 cores

Lung cancer tissue array, including TNM and pathology grade, 24 cases/72 cores

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/ 12 cores, replacing VLC12

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 192 cases/192 cores, replacing LC1921a

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing LC726

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores

Lung cancer tissue array, including TNM, stage and pathology grade, 12 cases/ 24 cores, replacing T045d

Lung cancer tissue array, with ALK results, , 150 cases/150 cores

Lung cancer tissue array, with ALK results, 150 cases/150 cores

Lung cancer tissue array, with ALK results, 150 cases/150 cores.

Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores

Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases/48 cores

Lung cancer tissue array, with TNM and grade info, 11 cases/11 cores

Lung cancer with matched adjacent and cancer adjacent tissue array, including TNM, clinical stage and pathology grade, 3 cores/case, replacing BC04022

Lung cancer with matched adjacent tissue array, including pathology grade, clinical stage(AJCC 7.0)I II III IV, with TNM score, survival information available. Surgery date 2004.7-2009.6, visit date...

Lung cancer with matched lymph node metastasis tissue array, including TNM and pathology grade, 40 cases/80 cores, replacing LC817

Lung cancer with necrosis tissue array, including TNM, clinical stage and pathology grade, 30 cases/30 cores

Lung cancer with normal lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 216 cases/216 cores

Lung cancer with normal tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 104 cases/208 cores

Lung carcinoma (multi-tissue combined panel) tissue array, 50 cases/100 cores

Lung carcinoma (multi-tissue combined panel) tissue array, including TNM, clinical stage and pathology grade, 18 cases/54 cores, replacing BC04021

Lung carcinoma (multi-tissue combined panel, 80 cases/80 cores) tissue array

Lung carcinoma tissue microarray, 60 cases. Tumor and matched normal adjacent tissue ,1 core/case.

Lung carcinoma,92 cases, tumor and matched NAT.

Lung disease and normal tissue array, 16 cases/48 cores

Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases/208 cores

Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases/80 cores

Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases/48 cores

Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replacing BC04002

Lung disease tissue array, 15 cases/15 cores

Lung large cell cancer and adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores

Lung large cell carcinoma tissue array, including TTF1-1 marker, pathology grade, TNM and clinical stage, 24 cases/72 cores

Lung mucinous adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 21 cases/21 cores

Lung non-small cell cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores

Lung non-small cell carcinoma tissue array with cancer adjacent lung tissue and normal lung tissue, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing LC10012a

Lung non-small cell carcinoma tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replaced by LC10011b

Lung small cell cancer tissue array, including pathology grade, TNM and clinical stage, 44 cases/44 cores, replacing LC703

Lung small cell cancer with normal lung tissue array, 55 cases/100 cores

Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores

Lung small cell carcinoma tissue array with normal lung tissue, including TNM, 40 cases/80 cores, replacing LC802b

Lung small cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores

Lung squamous carcinoma,90 cases, tumor and matched NAT.

Lung squamous cell carcinoma (grade I-III) tissue array with matched tumor adjacent and normal control, 33 cases/99 cores

Lung squamous cell carcinoma (grade III) tissue array, 21 cases/63 cores

Lung squamous cell carcinoma and adjacent normal tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BC04118

Lung squamous cell carcinoma tissue array (75 cases) and matched normal adjacent tissue (NAT.

Lung squamous cell carcinoma tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores

Lung squamous cell carcinoma tissue array, 32 cases.

Lung squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 76 cases/76 cores

Lung squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, with IHC of EGFR results, 50 cases/100 cores, replacing LC10015

Lung squamous cell carcinoma tissue array, tumor, NAT.

Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases/80 cores, replacing LC808a

Lung squamous cell carcinoma, 38 cases, tumor and matched NAT.

Lung squamous cell carcinoma, 75 cases, tumor and matched NAT.

Lung tuberculosis tissue array with normal tissue, 48 cases/100 cores

Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Lung tumor tissue array with normal Lung tissue, 40 cases/40 cores.

Lymph node and tonsil tissue array, 12 cases/ 24 cores, replaced by LY241d

Lymph node and tonsil tissue array, 12 cases/24 cores, replacing LY241f

Lymph node metastatic squamous cell carcinoma tissue array, 80 cases/80 cores

Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores

Lymphatic tissue array, 24 cases/48 cores

Lymphoma and normal lymph node tissue array, 24 cases/72 cores

Lymphoma array, together with LYM321, LYM761 and LYM771 forming the lymphoma array set, 39 cases/40 cores

Lymphoma cancer tissue array, 48 cases/48 cores, replacing NHL482

Lymphoma mid-density tissue array, non-overlapping with LYM1501, 75 cases/150 cores

Lymphoma mid-density tissue array, non-overlapping with LYM1502, 75 cases/150 cores

Lymphoma survey tissue array (2 of 5), 104 cases/208 cores

Lymphoma test tissue array, with normal lymph node control tissues, 6 cases/24 cores, replaced by T201a

Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases/80 cores, replacing LM801a

Lymphoma tissue array with normal lymph node tissue as control, 48 cases/48 cores, replaced by LM482c

Lymphoma tissue array with normal lymph node tissue as control, 80 cases/ 80 cores,no overlapping with LY800b

Lymphoma tissue array with normal lymph node tissue, 12 cases/ 24 cores, replacing T203b

Lymphoma tissue array with normal lymph node tissue, 48 cases/48 cores, replacing LM482b

Lymphoma tissue array, 18 cases/18 cores

Lymphoma tissue array, 20 cases/ 20 cores

Lymphoma tissue array, 30 cases/ 30 Cores (core size 2.0mm), replacing BS20011c. Previous Item# is BS20011d | LY302 | Gentaur UK, US & Europe Distribution

Lymphoma tissue array, 30 cases/ 30 cores, replacing BS20011b

Lymphoma tissue array, 48 cases/48 cores, replaced by NHL482

Lymphoma tissue array, 6 cases/24 cores

Lymphoma tissue array, including IHC markers (LCA and CD20) results 80 cases/80 cores, replacing NHL803d

Lymphoma tissue array, with normal lymph node tissue, 6 cases/24 cores, replacing T201a

Lymphoma tissue tissue array with normal tissue as control, 2 serial sections, 6 cases/24 cores, replacing T204

Lymphoma tumor survey tissue array (2 of 3), 208 cases/208 cores

Lymphoma tumor survey tissue array (3 of 5), with ALK, Ki-67, Bcl-2, CD30, CD20 and CD3 data, 104 cases/208 cores

Lymphoma tumor survey tissue array (5 of 5), with ALK, Ki-67, Bcl-2, CD30, CD20 and CD3 results, 104 cases/208 cores

Lymphoma tumor tissue array, 208 cases/208 cores

Lymphoma tumor tissue array, 75 cases/150 cores

Lymphoma with normal lymph node tissue array, 80 cases/ 80 cores, no overlapping with LY800a

Lymphoma with normal tissue survey array (1 of 5), 96 cases/192 cores, replacing LY2081

Lymphoma, myeloma and lymph node tissue array, 40 cases/40 cores, replacing NHL401

Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores

Malignant fibrohistiocytoma tissue array, 80 cases/80 cores

Malignant melanoma array with adjacent normal skin tissue, including TNM and clinical stage, 24 cases/24 cores, replaced by ME242c

Malignant melanoma array with adjacent normal skin tissue, including TNM and clinical stage, 24 cases/24 cores, replacing ME242b

Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases/24 cores